TP53 and Wilms tumor: We found a constrained driver landscape in children with pathogenic germline WT1 mutations which was, in particular, devoid of variants representing either high risk Wilms tumour (TP53, chromosome 17p loss) or those used by COG to intensify treatment (combined LOH of chromosome 1p and 16q, 1q gain).